Keyword: Merck & Co.

News

Pfizer to Spend $120 Million on US Paxlovid Buildup

14.06.2022 -

Pfizer will invest $120 million at its plant in Kalamazoo, Michigan, to support US production of its Paxlovid (nirmatrelvir) oral antiviral treatment for Covid-19. The...

News

FDA Greenlights GSK’s MMR Vaccine

07.06.2022 -

The US Food and Drug Administration (FDA) has greenlit GSK’s Priorix-branded GSK’s mumps and rubella vaccine (MMR) for people 12 months and older. It is only the second...

News

Merck & Co Collaborates with Curve

02.03.2022 -

US pharma group Merck & Co is collaborating with Curve Therapeutics, a privately-held UK biotech that has developed a proprietary functional drug discovery platform...

News

FDA Advisory Panel Narrowly Votes for Lagevrio EUA

03.12.2021 -

With a vote of 13 to 10, the Antimicrobial Drugs Advisory Committee, an advisory panel to the US Food and Drug Administration, narrowly decided to to recommend emergency...

News

Pfizer Lifts Paxlovid Capacity Before EUA is Granted

01.12.2021 -

In response to new data published by rival Merck that downgrade earlier efficacy forecasts for its for Covid-19 oral antiviral treatment, Pfizer has announced will...

News

UK’s MHRA Approves Merck & Co Covid Pill

05.11.2021 -

The UK has “pipped the US at the post”, as one commentator noted in typical British colloquialism on the news that the country’s health regulator MHRA has approved the...

News

EMA Begins Rolling Review of Molnupiravir

26.10.2021 -

The European Medicines Agency (EMA) has begun a rolling review of US Merck & Co’s oral antiviral molnupiravir as a candidate to treat Covid-19. The EU drugs regulator...

News

Merck & Co.’s $11.5 Billion Acceleron Deal May Face Hurdles

04.10.2021 -

US drugs giant Merck & Co. has signed a definitive agreement to acquire publicly traded US biotech Acceleron Pharma for $180 per share, yielding a total equity value of...